Donohue syndrome, also known as leprechaunism, is an extremely rare and severe genetic disorder. The older name derives from the mythical leprechaun, whose physical attributes resemble the hallmark elvish features of the condition: small stature, bulging eyes and upturned nostrils. The disease is caused by a mutation in the INSR gene, which carries the information for forming insulin receptors, so affected individuals have either fewer insulin receptors or receptors with greatly impaired function. The resulting severe insulin resistance prevents regulation of blood glucose and ultimately disturbs the development of tissues and organs throughout the body. Endocrine abnormalities can produce hyperglycemia, hypoglycemia, high blood insulin and enlargement of the sex organs.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable First Described Prevalence Band Causative Agent
Causative Agent (category) Sources
1. Donohue syndrome (Wikipedia)
Lead section
severe insulin resistance
Lead section [causative-agent-category]
caused by a mutation in the INSR gene
Lead section [disease-category]
extremely rare and severe genetic disorder
Lead section [body-system]
endocrine system abnormalities
Article text
Donohue syndrome was first identified in 1948 by Canadian pathologist William L.
View the Source2. Orphadata (Orphanet): Orphadata epidemiology, ORPHAcode 508
Orphadata (Orphanet)Orphanet epidemiology, ORPHAcode 508Quote, Orphanet epidemiology, ORPHAcode 508
"PrevalenceClass": "\u003c1 / 1 000 000", "PrevalenceGeographic": "Worldwide", "PrevalenceQualification": "Value and class", "PrevalenceType": "Point prevalence"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.